Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
life sciences & biomedicine (171) 171
science & technology (171) 171
humans (156) 156
hematology (118) 118
male (104) 104
female (101) 101
middle aged (93) 93
oncology (91) 91
aged (83) 83
adult (78) 78
antineoplastic combined chemotherapy protocols - therapeutic use (78) 78
biological and medical sciences (59) 59
medical sciences (59) 59
prognosis (51) 51
hematologic and hematopoietic diseases (49) 49
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (47) 47
treatment outcome (46) 46
chemotherapy (40) 40
disease-free survival (37) 37
adolescent (34) 34
neoplasm staging (33) 33
retrospective studies (33) 33
rituximab (33) 33
aged, 80 and over (32) 32
lymphoma (32) 32
antineoplastic combined chemotherapy protocols - adverse effects (27) 27
young adult (25) 25
abridged index medicus (24) 24
lymphomas (23) 23
cyclophosphamide - administration & dosage (22) 22
survival analysis (22) 22
antineoplastic combined chemotherapy protocols - administration & dosage (21) 21
hematology, oncology and palliative medicine (21) 21
recurrence (21) 21
tumors (21) 21
cancer (20) 20
combined modality therapy (20) 20
italy (20) 20
risk factors (20) 20
doxorubicin - administration & dosage (19) 19
prednisone - administration & dosage (19) 19
vincristine - administration & dosage (19) 19
antineoplastic agents - therapeutic use (18) 18
hemic and lymphatic diseases (18) 18
lymphoma, large b-cell, diffuse - drug therapy (18) 18
follow-up studies (16) 16
hodgkin disease - drug therapy (16) 16
lymphoma, follicular - pathology (16) 16
lymphoma, non-hodgkin - drug therapy (16) 16
antibodies, monoclonal, murine-derived - administration & dosage (14) 14
lymphoma, follicular - drug therapy (14) 14
stem cells (14) 14
care and treatment (13) 13
patients (13) 13
prospective studies (13) 13
remission induction (13) 13
stem cell transplantation (13) 13
survival rate (13) 13
antineoplastic agents (12) 12
clinical trials (12) 12
transplantation, autologous (12) 12
cyclophosphamide - therapeutic use (11) 11
hematopoietic stem cell transplantation (11) 11
hodgkin's disease (11) 11
lymphoma, large b-cell, diffuse - pathology (11) 11
research (11) 11
time factors (11) 11
bleomycin - administration & dosage (10) 10
cyclophosphamide (10) 10
disease management (10) 10
doxorubicin (10) 10
doxorubicin - therapeutic use (10) 10
follicular lymphoma (10) 10
hodgkin disease - mortality (10) 10
immunotherapy (10) 10
kaplan-meier estimate (10) 10
lymphoma, large b-cell, diffuse - mortality (10) 10
mantle cell lymphoma (10) 10
patient outcomes (10) 10
positron-emission tomography (10) 10
prednisone - therapeutic use (10) 10
transplantation (10) 10
vincristine - therapeutic use (10) 10
analysis (9) 9
antibodies, monoclonal, murine-derived - therapeutic use (9) 9
clinical trials as topic (9) 9
diffuse large b-cell lymphoma (9) 9
drug therapy (9) 9
hodgkin disease - therapy (9) 9
hodgkin lymphoma (9) 9
immune system diseases (9) 9
leukemia (9) 9
lymphoma, non-hodgkin - pathology (9) 9
lymphoma, non-hodgkin - therapy (9) 9
predictive value of tests (9) 9
salvage therapy (9) 9
antibodies, monoclonal - therapeutic use (8) 8
cyclophosphamide - adverse effects (8) 8
doxorubicin - adverse effects (8) 8
drug administration schedule (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Large B-cell lymphomas
by Vitolo, Umberto
HemaSphere, ISSN 2572-9241, 06/2019, Volume 3, p. 112
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text First-Line Treatment for Primary Testicular Diffuse Large B-Cell Lymphoma With Rituximab-CHOP, CNS Prophylaxis, and Contralateral Testis Irradiation: Final Results of an International Phase II Trial
by Umberto Vitolo and Annalisa Chiappella and Andrés J.M. Ferreri and Maurizio Martelli and Ileana Baldi and Monica Balzarotti and Chiara Bottelli and Annarita Conconi and Henry Gomez and Armando Lopez-Guillermo and Giovanni Martinelli and Francesco Merli and Domenico Novero and Lorella Orsucci and Vincenzo Pavone and Umberto Ricardi and Sergio Storti and Mary K. Gospodarowicz and Franco Cavalli and Andreas H. Sarris and Emanuele Zucca
Journal of clinical oncology, ISSN 0732-183X, 07/2011, Volume 29, Issue 20, pp. 2766 - 2772
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Doxorubicin - therapeutic use | Recurrence | Prospective Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Testicular Neoplasms - pathology | Central Nervous System Neoplasms - secondary | Testicular Neoplasms - radiotherapy | Central Nervous System Neoplasms - prevention & control | Drug-Related Side Effects and Adverse Reactions | Adult | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Lymphoma, Large B-Cell, Diffuse - pathology | Rituximab | Treatment Outcome | Lymphoma, Large B-Cell, Diffuse - radiotherapy | Methotrexate - adverse effects | Testicular Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Survival Analysis | Vincristine - therapeutic use | Vincristine - adverse effects | Methotrexate - administration & dosage | Aged | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Prednisone - therapeutic use | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Brentuximab vedotin-based salvage treatment in Hodgkin's lymphoma
by Vitolo, Umberto and Chiappella, Annalisa
The lancet oncology, ISSN 1470-2045, 09/2018, Volume 19, Issue 9, pp. 1144 - 1146
Life Sciences & Biomedicine | Oncology | Science & Technology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Salvage regimens for Hodgkin's lymphoma in the brentuximab vedotin era
by Vitolo, Umberto and Chiappella, Annalisa
The lancet oncology, ISSN 1470-2045, 02/2018, Volume 19, Issue 2, pp. 162 - 163
Life Sciences & Biomedicine | Oncology | Science & Technology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Partial response or better at 6 months is prognostic of superior progression-free survival in patients with Waldenstrom macroglobulinaemia treated with ibrutinib
by Vitolo, Umberto and Novo, Mattia and Santambrogio, Elisa
British journal of haematology, ISSN 0007-1048, 11/2020
Life Sciences & Biomedicine | Hematology | Science & Technology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial
by Vitolo, Umberto, Dr and Chiappella, Annalisa, MD and Franceschetti, Silvia, MD and Carella, Angelo Michele, MD and Baldi, Ileana, PhD and Inghirami, Giorgio, Prof and Spina, Michele, MD and Pavone, Vincenzo, MD and Ladetto, Marco, MD and Liberati, Anna Marina, Prof and Molinari, Anna Lia, MD and Zinzani, Pierluigi, Prof and Salvi, Flavia, MD and Fattori, Pier Paolo, MD and Zaccaria, Alfonso, MD and Dreyling, Martin, Prof and Botto, Barbara, MD and Castellino, Alessia, MD and Congiu, Angela, MD and Gaudiano, Marcello, PhD and Zanni, Manuela, MD and Ciccone, Giovannino, MD and Gaidano, Gianluca, Prof and Rossi, Giuseppe, MD and on behalf of the Fondazione Italiana Linfomi and Fdn Italiana Linfomi and Fondazione Italiana Linfomi
The lancet oncology, ISSN 1470-2045, 2014, Volume 15, Issue 7, pp. 730 - 737
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Thalidomide - adverse effects | Cyclophosphamide - administration & dosage | Prednisone - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Thalidomide - administration & dosage | Cyclophosphamide - adverse effects | Lymphoma, Large B-Cell, Diffuse - mortality | Thalidomide - analogs & derivatives | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged, 80 and over | Vincristine - administration & dosage | Vincristine - adverse effects | Female | Aged | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Doxorubicin - administration & dosage | Aged patients | Anthracyclines | Product development | Corticosteroids | Angiogenesis inhibitors | Public health | Analysis | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Monoclonal antibody-drug conjugates in B-cell lymphomas
by Chiappella, Annalisa and Vitolo, Umberto
The Lancet. Haematology, ISSN 2352-3026, 05/2019, Volume 6, Issue 5, pp. e232 - e233
Life Sciences & Biomedicine | Hematology | Science & Technology | Immunoconjugates - pharmacology | Humans | Immunotherapy | Lymphoma, B-Cell - diagnosis | Immunoconjugates - therapeutic use | Treatment Outcome | Combined Modality Therapy | Lymphoma, B-Cell - drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Rituximab and autologous stem-cell transplantation for high-risk diffuse large B-cell lymphoma – Authors' reply
by Chiappella, Annalisa and Martelli, Maurizio and Evangelista, Andrea and Vitolo, Umberto
The lancet oncology, ISSN 1470-2045, 10/2017, Volume 18, Issue 10, pp. e558 - e558
Transplantation | Lymphomas | Stem cells | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Recent advances in clinical studies and the evolving role of subtyping for patients with diffuse large B-cell lymphoma
by Nowakowski, Grzegorz S and Vitolo, Umberto
Future oncology (London, England), ISSN 1479-6694, 04/2017, Volume 13, Issue 10, pp. 859 - 862
hematologic/lymphoma | molecular oncology | chemotherapy
Journal Article
Details down arrow
10. Full Text Interim positron emission tomography response-adapted therapy in advanced-stage hodgkin lymphoma: Final results of the phase II part of the HD0801 study
by Zinzani, Pier Luigi and Broccoli, Alessandro and Gioia, Daniela Maria and Castagnoli, Antonio and Ciccone, Giovannino and Evangelista, Andrea and Santoro, Armando and Ricardi, Umberto and Bonfichi, Maurizio and Brusamolino, Ercole and Rossi, Giuseppe and Anastasia, Antonella and Zaja, Francesco and Vitolo, Umberto and Pavone, Vincenzo and Pulsoni, Alessandro and Rigacci, Luigi and Gaidano, Gianluca and Stelitano, Caterina and Salvi, Flavia and Rusconi, Chiara and Tani, Monica and Freilone, Roberto and Pregno, Patrizia and Borsatti, Eugenio and Sacchetti, Gian Mauro and Argnani, Lisa and Levis, Alessandro
Journal of clinical oncology, ISSN 0732-183X, 04/2016, Volume 34, Issue 12, pp. 1376 - 1385
Life Sciences & Biomedicine | Oncology | Science & Technology | Hodgkin Disease - diagnostic imaging | Predictive Value of Tests | Humans | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Positron-Emission Tomography | Patient Selection | Young Adult | Time Factors | Hodgkin Disease - mortality | Adult | Female | Stem Cell Transplantation - mortality | Risk Assessment | Risk Factors | Kaplan-Meier Estimate | Treatment Outcome | Disease Progression | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hodgkin Disease - therapy | Adolescent | Italy | Aged | Drug Substitution | Neoplasm Staging | Stem Cell Transplantation - adverse effects | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned
by Viviani, Simonetta and Zinzani, Pier Luigi and Rambaldi, Alessandro and Brusamolino, Ercole and Levis, Alessandro and Bonfante, Valeria and Vitolo, Umberto and Pulsoni, Alessandro and Liberati, Anna Marina and Specchia, Giorgina and Valagussa, Pinuccia and Rossi, Andrea and Zaja, Francesco and Pogliani, Enrico M and Pregno, Patrizia and Gotti, Manuel and Gallamini, Andrea and Scalabrini, Delia Rota and Bonadonna, Gianni and Gianni, Alessandro M and Intergrp Italiano Linfomi and Grp Italiano Terapie Innovative Ne and Michelangelo Fdn and Michelangelo Foundation and Intergruppo Italiano Linfomi and Gruppo Italiano di Terapie Innovative nei Linfomi
The New England journal of medicine, ISSN 0028-4793, 07/2011, Volume 365, Issue 3, pp. 203 - 212
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | General aspects | Medical sciences | Doxorubicin - therapeutic use | Dacarbazine - adverse effects | Dacarbazine - therapeutic use | Humans | Middle Aged | Salvage Therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Vinblastine - therapeutic use | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Young Adult | Hodgkin Disease - radiotherapy | Bleomycin - therapeutic use | Vinblastine - adverse effects | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Adult | Female | Etoposide - adverse effects | Prednisone - adverse effects | Kaplan-Meier Estimate | Proportional Hazards Models | Hematopoietic Stem Cell Transplantation | Etoposide - therapeutic use | Combined Modality Therapy | Bleomycin - adverse effects | Remission Induction | Disease-Free Survival | Procarbazine - adverse effects | Procarbazine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hodgkin Disease - therapy | Adolescent | Vincristine - therapeutic use | Vincristine - adverse effects | Neoplasm Staging | Doxorubicin - adverse effects | Prednisone - therapeutic use | Procarbazine | Vinblastine | Disease | Etoposide | Prednisone | Family medical history | Radiation therapy | Patients | Lymphoma | Doxorubicin | Survival | Vincristine | Studies | Hepatitis | Dacarbazine | Cyclophosphamide | Chemotherapy | Bleomycin | Tomography | Hodgkin's disease | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial
by Horwitz, Steven and O'Connor, Owen A and Pro, Barbara and Illidge, Tim and Fanale, Michelle and Advani, Ranjana and Bartlett, Nancy L and Christensen, Jacob Haaber and Morschhauser, Franck and Domingo-Domenech, Eva and Rossi, Giuseppe and Kim, Won Seog and Feldman, Tatyana and Lennard, Anne and Belada, David and Illés, Árpád and Tobinai, Kensei and Tsukasaki, Kunihiro and Yeh, Su-Peng and Shustov, Andrei and Hüttmann, Andreas and Savage, Kerry J and Yuen, Sam and Iyer, Swaminathan and Zinzani, Pier Luigi and Hua, Zhaowei and Little, Meredith and Rao, Shangbang and Woolery, Joseph and Manley, Thomas and Trümper, Lorenz and Aboulafia, David and Advani, Ranjana and Alpdogan, Onder and Ando, Kiyoshi and Arcaini, Luca and Baldini, Luca and Bellam, Naresh and Bartlett, Nancy and Belada, David and Yehuda, Dina Ben and Benedetti, Fabio and Borchman, Peter and Bordessoule, Dominique and Brice, Pauline and Briones, Javier and Caballero, Dolores and Carella, Angelo Michele and Chang, Hung and Cheong, June Weon and Cho, Seok-Goo and Choi, Ilseung and Choquet, Sylvain and Colita, Andrei and Congui, Angela Giovanna and D'amore, Francesco and Dang, Nam and Davison, Kelly and de Guibert, Sophie and Brown, Peter de Nully and Delwail, Vincent and Demeter, Judit and di Raimondo, Francesco and Do, Young Rok and Domingo, Eva and Douvas, Michael and Dreyling, Martin and Ernst, Thomas and Fanale, Michelle and Fay, Keith and Feldman, Tatyana and Ferrero, Silvia Fernandez and Flinn, Ian Winchester and Forero-Torres, Andres and Fox, Christopher and Friedberg, Jonathan and Fukuhara, Noriko and Garcia-Marco, Jose and Cruz, Jorge Gayoso and Codina, Jose Gomez and Gressin, Remy and Grigg, Andrew and Gurion, Ronit and Christensen, Jacob Haaber and Haioun, Corinne and Hajek, Roman and Hanel, Mathias and Hatake, Kiyohiko and Hensen, Robert and Horowitz, Netanel and Horwitz, Steven and Huttmann, Andreas and Illes, Arpad and Illidge, Tim and Ishizawa, Kenichi and Islas-Ohlmayer, Miguel and Jacobsen, Eric and Janakiram, Murali and Jurczak, Wojciech and Kaminski, Mark and ... and ECHELON-2 Study Group and ECHELON 2 Study Grp
The Lancet (British edition), ISSN 0140-6736, 01/2019, Volume 393, Issue 10168, pp. 229 - 240
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cyclophosphamide - administration & dosage | Prednisone - administration & dosage | Double-Blind Method | Humans | Middle Aged | Immunologic Factors - administration & dosage | Male | Antineoplastic Agents - administration & dosage | Immunoconjugates - administration & dosage | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, Large-Cell, Anaplastic - drug therapy | Intention to Treat Analysis | Vincristine - administration & dosage | Adult | Female | Aged | Immunologic Factors - adverse effects | Brentuximab Vedotin | Doxorubicin - administration & dosage | Immunoconjugates - adverse effects | Leukemia | Clinical trials | Lymphocytes T | Peripheral neuropathy | Cancer therapies | Doxorubicin | Evidence-based medicine | Regulatory approval | Randomization | CD30 antigen | Safety management | Genetics | Safety | Active control | Neutropenia | Cell survival | Prednisone | Patients | Survival | Vincristine | Lymphoma | Cyclophosphamide | Chemotherapy | Medical prognosis | Adults | Interferon | Anaplastic large-cell lymphoma | T-cell lymphoma | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project
by Massimo Federico and Monica Bellei and Luigi Marcheselli and Stefano Luminari and Armando Lopez-Guillermo and Umberto Vitolo and Barbara Pro and Stefano Pileri and Alessandro Pulsoni and Pierre Soubeyran and Sergio Cortelazzo and Giovanni Martinelli and Maurizio Martelli and Luigi Rigacci and Luca Arcaini and Francesco Di Raimondo and Francesco Merli and Elena Sabattini and Peter McLaughlin and Philippe Solal-Céligny
Journal of clinical oncology, ISSN 0732-183X, 09/2009, Volume 27, Issue 27, pp. 4555 - 4562
Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Predictive Value of Tests | Lymphoma, Follicular - therapy | Prognosis | Risk Assessment | Humans | Middle Aged | Lymphoma, Follicular - diagnosis | Disease Progression | Young Adult | Disease-Free Survival | Aged, 80 and over | Adult | Aged | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Addition of Rituximab to Chlorambucil Produces Superior Event-Free Survival in the Treatment of Patients With Extranodal Marginal-Zone B-Cell Lymphoma: 5-Year Analysis of the IELSG-19 Randomized Study
by Emanuele Zucca and Annarita Conconi and Daniele Laszlo and Armando López-Guillermo and Reda Bouabdallah and Bertrand Coiffier and Catherine Sebban and Fabrice Jardin and Umberto Vitolo and Franck Morschhauser and Stefano A. Pileri and Christiane Copie-Bergman and Elias Campo and Andrew Jack and Irene Floriani and Peter Johnson and Maurizio Martelli and Franco Cavalli and Giovanni Martinelli and Catherine Thieblemont
Journal of clinical oncology, ISSN 0732-183X, 02/2013, Volume 31, Issue 5, pp. 565 - 572
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Chlorambucil - administration & dosage | Drug Administration Schedule | Follow-Up Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Kaplan-Meier Estimate | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Rituximab | Male | Treatment Outcome | Remission Induction | Lymphoma, B-Cell, Marginal Zone - mortality | Disease-Free Survival | Analysis of Variance | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, B-Cell, Marginal Zone - drug therapy | Adult | Female | Aged | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Early Interim 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Study
by Andrea Gallamini and Martin Hutchings and Luigi Rigacci and Lena Specht and Francesco Merli and Mads Hansen and Caterina Patti and Annika Loft and Francesco Di Raimondo and Francesco D'Amore and Alberto Biggi and Umberto Vitolo and Caterina Stelitano and Rosario Sancetta and Livio Trentin and Stefano Luminari and Emilio Iannitto and Simonetta Viviani and Ivana Pierri and Alessandro Levis
Journal of clinical oncology, ISSN 0732-183X, 08/2007, Volume 25, Issue 24, pp. 3746 - 3752
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Tumors | Hodgkin Disease - diagnostic imaging | Prognosis | Humans | Middle Aged | Male | Survival Rate | Disease-Free Survival | Adolescent | Radionuclide Imaging | Hodgkin Disease - drug therapy | Hodgkin Disease - mortality | Adult | Female | Fluorodeoxyglucose F18 | Aged | Radiopharmaceuticals | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights